Methods A randomized, open-label, controlled trial was conducted at the Asian Institute of Gastroenterology, Hyderabad, from June 2022 to December 2023
Coverage and accessibility is definitely going to be the biggest challenge as we move forward in treating people with obesity. Benefits beyond weight loss In August, Novo Nordisk, the maker of Ozempic and Wegovy, became the first to demonstrate in a large clinical trial that the drugs provide health benefits beyond weight loss and diabetes management
Rybelsus helps to lower blood sugar levels by stimulating insulin production in response to high blood glucose and reducing the livers glucose production
In large trials, people continued losing weight for many months, but progress started to level off after about a year, with weight stabilizing around that point
But for folks living with type 2 diabetes, keeping blood sugars under good control can help prevent severe vision loss, and even slow progression of retinopathy